Agenda
John M. Kirkwood, MD University of Pittsburgh Medical Center
Efficacy and Safety of Adjuvant High-Dose Interferon for Melanoma from ECOG and Intergroup Trials
Joseph G. Ibrahim, PhD Harvard School of Public Health
Cure Rate Model Trial Design
C
Previous slide
Next slide
Back to first slide
View graphic version